Company: DMAAR
Filing Date: 2025-11-18
Form Type: 10-Q
Source: 0001213900-25-112096
Chunk: 20

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-11-18
Form: 10-Q
Item: Part I, Item 1
Chunk 20
---
    Redeemable
    shares  
    Non-redeemable
    shares  
    Redeemable
    shares  
    Non-redeemable
    shares 
  
    Basic net income per share: 

    Numerator: 

    Allocation of
    net income 
    $1,499,082  
    $685,481  
    $3,813,036  
    $1,914,649 
  
    Denominator: 

    Weighted-average shares outstanding 
     23,000,000  
     10,517,143  
     20,336,996  
     10,211,868 
  
    Basic
    net income per ordinary share 
    $0.07  
    $0.07  
    $0.19  
    $0.19 

    Diluted net income per share: 

    Numerator: 

    Allocation of net income 
    $1,499,082  
    $685,481  
    $3,783,124  
    $1,944,561 
  
    Denominator: 

    Weighted-average shares outstanding 
     23,000,000  
     10,517,143  
     20,336,996  
     10,453,407 
  
    Diluted
    net income per ordinary share 
    $0.07  
    $0.07  
    $0.19  
    $0.19 

    Three Months Ended September 30, 2024  
    For The Period from
 May 23, 2024  (Inception) through September 30, 2024 

    Redeemable  
    Non-Redeemable  
    Redeemable  
    Non-Redeemable 
  
    Basic and diluted net loss per share: 

    Numerator: 

    Allocation of net loss 
    $—  
    $(144,928) 
    $—  
    $(199,859)
  
    Denominator: 

    Weighted-average shares outstanding 
     —  
     8,571,429  
     —  
     8,571,429 
  
    Basic and diluted net loss per ordinary share 
    $—  
    $(0.02) 
    $—